"Will I regain weight after stopping medication?" Evidence suggests weight often returns after stopping GLP-1 treatment, which is why clinician-led maintenance planning and lifestyle support are important
Retatrutide and tirzepatide each have their own independent clinical development programs and datasets, but the fixed-ratio combination of the two has not been evaluated in a dedicated clinical trial
Risk factors of CVDs, which are grouped into modifiable and non-modifiable, include hypertension, smoking, hyperlipidemia, being overweight and having a sedentary lifestyle
Strong AHAs/BHAs (Glycolic, Salicylic Acid): Using these with kojic acid can lead to excessive exfoliation, leading to irritation, redness, and patchy pigmentation, especially if you have sensitive or dusky skin
All GLP-1 medications, whether brand-name or compounded, require a prescription from a licensed healthcare provider after a medical evaluation